Print

HVTN 105

A Phase 1b Clinical Trial to Evaluate the Safety and Immunogenicity of Different Combinations of DNA-HIV-PT123 and AIDSVAX? B/E in Healthy, HIV Uninfected Adult Participants

Trial Details:

Ib Completed
National Institute of Allergy and Infectious Diseases (NIAID) July 31, 2014
AIDSVAX B/E,DNA-HIV-PT123 DNA Gag, Env gp140, Pol-Nef C; Protein Env B/E
AIDSVAX B/E Protein
DNA-HIV-PT123 DNA
USA 104
http://www.clinicaltrials.gov/ct2/show/NCT02207920